Admission Date: [**2151-1-2**]        Discharge Date: [**2151-2-16**]  Date of Birth:  [**2151-1-2**]        Sex:  M  Service:  NB   HISTORY:  Baby [**Name (NI) **] [**Known lastname **] is a preterm infant with respiratory symptoms admitted for Newborn Intensive Care Unit management.
Prenatal screens: Blood type A positive, antibody negative, hepatitis B surface antigen negative, RPR nonreactive, rubella immune, group B Strep status unknown.
This antepartum remarkable for known anticardiolipin antibody treated with aspirin and low molecular weight Heparin.
She received betamethasone complete on day of delivery.
Fetal tracing non-reassuring and decision made to deliver by repeat cesarean section.
Infant was transferred to the Newborn Intensive Care Unit with oxygen without incident.
PHYSICAL EXAMINATION:  Exam remarkable for pink infant on continuous positive airway pressure with weight of 1850 grams (50th percentile).
SUMMARY OF HOSPITAL COURSE BY SYSTEMS:  Respiratory:  The infant was placed on continuous positive airway pressure of 6 cm shortly after admission to the Newborn Intensive Care Unit.
He was weaned off of continuous positive airway pressure to room air by day of life four.
Caffeine citrate was started on day of life three for apnea of prematurity.
The caffeine was subsequently discontinued on day of life 14.
Fluid, electrolytes, and nutrition:  IV fluids of D10W were started at 80 cc/kg/day upon admission to the Newborn Intensive Care Unit.
Enteral feeds were started on day of life one.
Phototherapy was started at that time.
Phototherapy was discontinued on day of life six with a rebound bilirubin of 6.6 on day of life seven.
He did not receive any blood products during his hospitalization.
He received a 48 hour course of ampicillin and gentamicin.
Immunizations received:  [**Known lastname **] received his first dose of Synagis on [**2-4**].
Parents have requested to defer immunizations until one month after [**Known lastname 55412**] original due date.
Immunizations recommended:  Synagis RSV prophylaxis should be considered from [**Month (only) **] through [**Month (only) 958**] for infants who meet any of the three criteria:  1.
Influenza immunization is recommended annually in the fall for all infants once they reach six months of age.
Before this age and for the first 24 months of the child's life, immunization against influenza is recommended for household contacts and out of home caregivers.
